Prognostic Value of Dual-time-point 18F-FDG PET in Fibrotic Idiopathic Interstitial Pneumonia

Prognostic Value of Dual-time-point 18F-FDG PET in Fibrotic Idiopathic Interstitial Pneumonia - Prognostic Value of Dual-time-point 18F-FDG PET in Fibrotic Idiopathic Interstitial Pneumonia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010498

Enrollment

Registered

2013-04-15

Start date

2007-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic interstital pneumonia

Interventions

All patients with idiopathic interstitial pneumonia undergo dual-time-point 18F-FDG PET of thorax.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Eligible patients were men and women aged 18 years or older with a proven diagnosis of IPF or idiopathic fibrotic NSIP according to the American Thoracic Society/European Respiratory Society statement, with less than 3 years' duration.

Exclusion criteria

Exclusion criteria: Patients with defined connective tissue disease, left ventricular failure, occupational and/or environmental exposure that resulted in interstitial pneumonia, or history of ingestion of a drug or agent known to cause pulmonary fibrosis were excluded from the study.

Design outcomes

Primary

Measure	Time frame
Overall survival after 18F-FDG PET examination	—

Secondary

Measure	Time frame
1-year change of pulmanary function tests and computed tomography findings after 18F-FDG PET examination	—

Countries

Japan

Contacts

Public ContactYukihiro Umeda

Faculty of Medical Sciences, University of Fukui Third Department of Internal Medicine

umeda@u-fukui.ac.jp0776-61-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026